z-logo
open-access-imgOpen Access
VIVAX MALARIA
Author(s) -
Ghulam Mustafa Mangrio,
Mushtaq Ali Memon,
Mumtaz Ali Shaikh,
Hamid Nawaz Ali Memon,
Suneel Arwani,
Syed Zulfiquar Ali Shah
Publication year - 2015
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2015.22.05.1267
Subject(s) - medicine , malaria , vivax malaria , plasmodium vivax , red blood cell distribution width , gastroenterology , pediatrics , immunology , plasmodium falciparum
Objective: To determine the frequency and severity of thrombocytopenia and toevaluate the variation of red cell distribution width (RDW) in patients with acute vivax malaria.Study Deign: Cross sectional descriptive case series study. Period: Six months. Setting:Liaquat University Hospital. Methods: All the patients with acute vivax malaria were evaluatedfor thrombocytopenia its severity and RDW. The data was analyzed in SPSS 10 and thefrequency and percentage was calculated. Results: Total 126 patients with acute vivax malariawere recruited, of which 88 were males and 38 were females. The mean age ±SD for male andfemale subjects was 44.76±6.83 and 40.83±7.42. The common features observed were fever31%, rigor 15% and combined features 14% (p=0.05). The thrombocytopenia was identified in86 patients of which 65 were males and 21 were females (p=0.04). The increased RDW wasobserved in 75 patients of which 57 were males and 18 were females (p=0.05). The bleedingwas detected in 56 and dyspnea and heart failure was found in 30 thrombocytopenic subjects(p=0.02). Regarding outcome 82 subjects were recovered while the 04 patients were expired(p=0.05). Regarding severity of thrombocytopenia majority 48.8% were in moderate categorywith male predominance (p=0.02). Conclusion: The thrombocytopenia and increased RDWwas observed in patients with acute vivax malaria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here